Cargando…

Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma

BACKGROUND: Presently, CD133 is one of the hottest markers to characterize cancer stem cells and KAI1/CD82 is reported as an important marker for the metastasis and prognosis of many cancers. The purpose of our study is to explore the relationship between cancer stem cells (CSCs) marked by CD133 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Lan, Zhou, Lei, Wu, Shiwu, Gong, Xiaomeng, Feng, Zhenzhong, Ma, Li, Zhu, Bo, Yao, Nan, Wang, Danna, Dong, Huiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012248/ https://www.ncbi.nlm.nih.gov/pubmed/24758564 http://dx.doi.org/10.1186/1477-7819-12-118

Ejemplares similares

Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer
por: Zhou, Lei, et al.
Publicado: (2015)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
por: WANG, GENGMING, et al.
Publicado: (2015)

Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer
por: Wang, Yichao, et al.
Publicado: (2018)

Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma
por: Wu, Qiong, et al.
Publicado: (2015)

Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
por: Yan, Wei, et al.
Publicado: (2021)

Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1
por: Ordas, Laura, et al.
Publicado: (2021)

Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance
por: Ji, Hongyan, et al.
Publicado: (2017)

Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells
por: Odintsova, E, et al.
Publicado: (2006)

KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers
por: Wang, Shuo, et al.
Publicado: (2022)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance
por: Lu, Guoyu, et al.
Publicado: (2016)

Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma
por: Uchida, S, et al.
Publicado: (1999)

Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer
por: Viera, Maximillian, et al.
Publicado: (2021)

Identification and characterization of CD133(+)CD44(+) cancer stem cells from human laryngeal squamous cell carcinoma cell lines
por: Wang, Jue, et al.
Publicado: (2017)

Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer
por: Chai, Juan, et al.
Publicado: (2017)

Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer
por: Al-Khater, Khulood M., et al.
Publicado: (2021)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Limited Value of KAI1/CD82 Protein Expression as a Prognostic Marker in Human Gastric Cancer
por: Knoener, Maximilian, et al.
Publicado: (2012)

KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state
por: Lee, Jin-Woo, et al.
Publicado: (2021)

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
por: Wu, Shiwu, et al.
Publicado: (2012)

miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells
por: Mine, Mariko, et al.
Publicado: (2015)

KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model
por: Wang, Gengming, et al.
Publicado: (2018)

Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies
por: Zhu, Jundong, et al.
Publicado: (2017)

Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients
por: Latha, Thammineni Krishna, et al.
Publicado: (2019)

Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma
por: Zheng, Zongzhu, et al.
Publicado: (2017)

Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients
por: Singh, Alok, et al.
Publicado: (2018)

Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma
por: Zhu, Bo, et al.
Publicado: (2017)

Expression of KAI1 and AGR2 in lung adenocarcinoma and their clinicopathological significance
por: Ci, Hongfei, et al.
Publicado: (2022)

The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma
por: Zhu, Jundong, et al.
Publicado: (2017)

DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
por: Cheah, Phaik-Leng, et al.
Publicado: (2018)

Clinicopathological Significance of Expression of CD44 Variants in Head and Neck Squamous Cell Carcinoma
por: Kanke, Minoru, et al.
Publicado: (2000)

The Clinical Significance of CD163+ Tumor-Associated Macrophages (TAMs) in Laryngeal Squamous Cell Carcinoma
por: Ouban, Abderrahman, et al.
Publicado: (2023)

The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling
por: Lee, Jaeseob, et al.
Publicado: (2016)

Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD(82) Cell Line
por: Wang, Shuo, et al.
Publicado: (2021)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

CD82 expression marks the endothelium to hematopoietic transition at the onset of blood specification in human
por: Menegatti, Sara, et al.
Publicado: (2023)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line
por: Qiu, Hai-ou, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k73g3mlg7gnkdnapb2rqj8irvh